As of November 6, 2026, Novavax Inc. is a publicly traded company (Nasdaq: NVAX). The largest holder reporting an active stake on Schedule 13D is Shah Capital Management, at 6.46%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include State Street (7.1%), Himanshu H. Shah (6.46%), Vanguard (5.09%) (Schedule 13D/A, October 16, 2026).
Is this your company?
About to sign with, pay or invest in Novavax Inc.? See the free Snapshot first.
Free to see. No signup.
Is Novavax Inc. a real, registered company?
- Novavax, Inc. files with the SEC under CIK 1000694 (its SEC filings).
- Its shares are listed under the ticker NVAX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Gaithersburg, Maryland, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under NOVAVAX, INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Shah Capital Management (filed 2026-10-16).
Who are Novavax Inc.'s owners and officers?
Novavax Inc.: incorporated in Delaware; business address in Gaithersburg, Maryland; industry Biological Products, (No Diagnostic Substances) (Schedule 13D/A, 2026-10-16).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-16 | Shah Capital Management | 6.46% |
| Schedule 13G, 2026-10-16 | Himanshu H. Shah | 6.46% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 7.1% |
| Schedule 13D/A, 2026-05-15 | Shah Capital Management | 9.03% |
| Schedule 13G, 2026-04-30 | Vanguard Capital Management | 5.09% |
| Schedule 13G/A, 2026-04-27 | Bank Of America Corp /De/ | 4.1% |
| Schedule 13D/A, 2026-04-08 | Shah Capital Management | 9.11% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-11 | Bank Of America Corp /De/ | 5.1% |
| Schedule 13G, 2026-02-09 | State Street Corporation | 5.9% |
| Schedule 13D/A, 2025-11-12 | Shah Capital Management | 8.3% |
| Schedule 13D/A, 2025-10-14 | Shah Capital Management | 7.3% |
Questions about who owns Novavax Inc.
Who owns Novavax Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Novavax Inc.: State Street Corporation (7.1%, Schedule 13G, filed 2026-08-07), Shah Capital Management (6.46%, Schedule 13D/A, filed 2026-10-16), Himanshu H. Shah (6.46%, Schedule 13G, filed 2026-10-16) and Vanguard Capital Management (5.09%, Schedule 13G, filed 2026-04-30).
Who are the largest shareholders of Novavax Inc.?
By the share each holder's latest filing reports, the largest holders of Novavax Inc. on this page are State Street Corporation (7.1%), Shah Capital Management (6.46%) and Himanshu H. Shah (6.46%).
When did State Street Corporation buy into Novavax Inc.?
The filings give report dates, not purchase dates. The earliest filing from State Street Corporation on this page is the Schedule 13G, filed 2026-02-09, reporting 5.9%; its latest, Schedule 13G filed 2026-08-07, reports 7.1%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Novavax Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Novavax Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Novavax Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Novavax Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 225,680 shares (0.14% of shares outstanding) (Form 4, 2026-03-05).
- , the executive vice president and chief strategy officer: 134,642 shares (0.08% of shares outstanding) (Form 4, 2026-03-05).
- , the chief financial officer and executive vice president: 130,599 shares (0.08% of shares outstanding) (Form 4, 2026-03-09).
- , the executive vice president and chief legal officer: 90,067 shares (0.05% of shares outstanding) (Form 4, 2026-03-05).
- , a director: 79,770 shares (0.05% of shares outstanding) (Form 4, 2026-06-23).
Shares outstanding: 165,009,009 as of 2026-10-31, from the company's latest SEC cover page.
How much has Novavax Inc. raised?
No fundraising or offering filing from Novavax Inc. is on file with us.
Keep reading
More on Novavax Inc. and the records around it.
Novavax Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Shah Capital Management also filed stake reports on 3 other companies: VEON Ltd. (Oct 2026), Cheer Holding, Inc. (Oct 2025)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/novavax